IMCR · Immunocore Holdings plc · Held by Funds
Market Cap
$1.58B
Shares
51.50M
Volume · Oct 5
329.46K
Avg daily vol (3M)
456.79K
Registered funds — mutual funds, ETFs and closed-end funds — whose latest Form N-PORT portfolio report holds this exact listed security, matched by CUSIP. Each row is one fund position with its size, value and weight in that fund.
Funds holding IMCR
57 fund positions| Fund | Ticker | Balance | Value | % of Fund | Side | Reported | Open |
|---|---|---|---|---|---|---|---|
| PRIMECAP Odyssey Aggressive Growth Fund | POAGX | 1,111,200 | $37,569,672 | 0.51% | Long | 2026-07-31 | |
| Fidelity Growth Company Fund | — | 1,121,692 | $32,405,682 | 0.03% | Long | 2026-05-31 | |
| T. Rowe Price Health Sciences Fund, Inc. | — | 645,268 | $20,487,259 | 0.17% | Long | 2026-06-30 | |
| Select Health Care Portfolio | — | 500,000 | $14,445,000 | 0.25% | Long | 2026-05-31 | |
| BlackRock Health Sciences Term Trust | BMEZ | 359,126 | $11,402,251 | 1.06% | Long | 2026-06-30 | |
| Fidelity Growth Company K6 Fund | FGKFX | 330,328 | $9,543,176 | 0.03% | Long | 2026-05-31 | |
| iShares Biotechnology ETF | IBB | 299,288 | $9,502,394 | 0.10% | Long | 2026-06-30 | |
| MFS New Discovery Fund | — | 304,295 | $8,791,083 | 0.41% | Long | 2026-05-31 | |
| Fidelity Advisor Health Care Fund | — | 260,000 | $8,790,600 | 0.28% | Long | 2026-07-31 | |
| Select Biotechnology Portfolio | FBIOX | 287,200 | $8,297,208 | 0.16% | Long | 2026-05-31 | |
| Fidelity Series Growth Company Fund | FCGSX | 261,570 | $7,556,757 | 0.03% | Long | 2026-05-31 | |
| SmallCap Fund | — | 217,900 | $7,367,199 | 0.35% | Long | 2026-07-31 | |
| BlackRock Health Sciences Opportunities Portfolio | — | 188,691 | $5,451,283 | 0.09% | Long | 2026-05-29 | |
| Old Westbury Small & Mid Cap Strategies Fund | OWSMX | 159,882 | $5,405,610 | 0.06% | Long | 2026-07-31 | |
| Fidelity Capital Appreciation Fund | — | 158,900 | $5,372,409 | 0.07% | Long | 2026-07-31 | |
| THE HARTFORD HEALTHCARE FUND | — | 108,668 | $3,674,065 | 0.48% | Long | 2026-07-31 | |
| MFS New Discovery Series | — | 102,016 | $3,239,008 | 0.40% | Long | 2026-06-30 | |
| VIP Health Care Portfolio | — | 84,000 | $2,667,000 | 0.23% | Long | 2026-06-30 | |
| State Street(R) SPDR(R) Portfolio Developed World ex-US ETF | SPDW | 63,742 | $2,023,809 | 0.01% | Long | 2026-06-30 | |
| Virtus Biotech Etf | BBP | 46,863 | $1,584,438 | 1.61% | Long | 2026-07-31 | |
| ALPS Medical Breakthroughs ETF | SBIO | 52,254 | $1,509,618 | 0.93% | Long | 2026-05-31 | |
| T. Rowe Price Health Sciences Portfolio | — | 43,439 | $1,379,188 | 0.18% | Long | 2026-06-30 | |
| VOYA MULTI-MANAGER INTERNATIONAL SMALL CAP FUND | — | 37,273 | $1,260,200 | 0.22% | Long | 2026-07-31 | |
| Steward Values Enhanced International Fund | — | 35,726 | $1,207,896 | 0.36% | Long | 2026-07-31 | |
| State Street(R) SPDR(R) S&P(R) International Small Cap ETF | GWX | 34,287 | $1,088,612 | 0.13% | Long | 2026-06-30 | |
| Tema Oncology ETF | CANC | 30,849 | $891,228 | 0.51% | Long | 2026-05-31 | |
| Large-Cap Growth Portfolio | — | 25,652 | $814,451 | 0.06% | Long | 2026-06-30 | |
| Fidelity Nasdaq Composite Index Fund | FNCMX | 26,042 | $752,353 | 0.00% | Long | 2026-05-31 | |
| SmallCap Account | — | 19,700 | $625,475 | 0.32% | Long | 2026-06-30 | |
| iShares International Small-Cap Equity Factor ETF | ISCF | 17,076 | $577,340 | 0.09% | Long | 2026-07-31 | |
| Fidelity Nasdaq Composite Index ETF | ONEQ | 19,801 | $572,051 | 0.01% | Long | 2026-05-31 | |
| Nationwide International Small Cap Fund | — | 16,155 | $546,201 | 0.19% | Long | 2026-07-31 | |
| BlackRock Health Sciences Trust | BME | 16,565 | $525,939 | 0.09% | Long | 2026-06-30 | |
| Harbor International Core Fund | — | 14,632 | $494,708 | 0.02% | Long | 2026-07-31 | |
| HARTFORD HEALTHCARE HLS FUND | — | 15,428 | $489,839 | 0.44% | Long | 2026-06-30 | |
| Health Sciences Trust | — | 13,301 | $422,307 | 0.17% | Long | 2026-06-30 | |
| EQ/T.Rowe Price Health Sciences Portfolio | — | 11,527 | $365,982 | 0.21% | Long | 2026-06-30 | |
| Health Sciences Portfolio | — | 11,435 | $363,061 | 0.10% | Long | 2026-06-30 | |
| Archer Growth ETF | — | 10,806 | $312,185 | 2.42% | Long | 2026-05-31 | |
| Amplify Treatments, Testing and Advancements ETF | — | 9,166 | $310,636 | 3.36% | Long | 2024-06-30 | |
| Blackstone Alternative Multi-Strategy Fund | — | 7,900 | $250,825 | 0.01% | Long | 2026-06-30 | |
| International Opportunities Fund | VIOPX | 7,949 | $229,647 | 0.08% | Long | 2026-05-31 | |
| VIP Dynamic Capital Appreciation Portfolio | — | 5,700 | $180,975 | 0.06% | Long | 2026-06-30 | |
| Range Cancer Therapeutics ETF | CNCR | 4,770 | $140,095 | 1.57% | Long | 2025-02-28 | |
| AVIP Fidelity Institutional AM Equity Growth Portfolio | — | 4,330 | $137,478 | 0.06% | Long | 2026-06-30 | |
| Multi-Manager U.S. Small Cap Equity Fund | MMSMX | 3,458 | $96,513 | 0.03% | Long | 2026-04-30 | |
| Guardian Large Cap Fundamental Growth VIP Fund | — | 2,714 | $86,170 | 0.05% | Long | 2026-06-30 | |
| Invesco RAFI Developed Markets ex-U.S. Small-Mid ETF | PDN | 2,035 | $68,803 | 0.02% | Long | 2026-07-31 | |
| ActivePassive International Equity ETF | APIE | 2,381 | $68,787 | 0.01% | Long | 2026-05-31 | |
| Invesco Nasdaq Biotechnology ETF | IBBQ | 2,351 | $67,920 | 0.10% | Long | 2026-05-31 |
Showing 1–50 of 57 positions